Webinar On-Demand

Optimize liver cancer care and improve patient outcome

Bayer Asia PacificLiver Imaging Webinar

Feb22
(thu)
2024

Early Diagnosis

Diagnosis and management of pre-malignant lesions: impact on treatment choice and patient outcomes
Role of MRI surveillance in patients with higher HCC risk

Role of MRI surveillance in mins patients with higher HCC risk

Role of MRI surveillance in patients with higher HCC risk

Dr. Dong Hyun Sinn
Hepatologist, South Korea

Diagnosis and management of pre-vascular lesion: impact on treatment choice and patient outcome

Diagnosis and management of pre-vascular lesion: impact on treatment choice and patient outcome

Dr. Chien-An Liu
Radiologist, Taiwan

More Details

Apr24
(wed)
2024

Optimized Surgical and Interventional Therapies

Role of MRI before surgical HCC treatment
Role of MRI in patients receiving locoregional treatment

Unveiling the value of MRI imaging in improving surgical planning for HCC treatment

Unveiling the value of MRI imaging in improving surgical planning for HCC treatment

Dr. Zhong Guo Zhou
Surgeon, China

Refining treatment care in patients receiving ablation or TACE therapies through MRI imaging

Refining treatment care in patients receiving ablation or TACE therapies through MRI imaging

Dr. Nakarin Inmutto
Interventional radiologist, Thailand

More Details

Jun25
(tue)
2024

Improved Patient Management

Prognosis prediction of HCC based on MRI imaging: features of aggressive HCC
Role of MRI in HCC systemic treatment response prediction and evaluation

Prognosis prediction of HCC based on MRI features: features of aggressive HCC

Prognosis prediction of HCC based on MRI features: features of aggressive HCC

Dr. Hyungjin Rhee
Radiologist, South Korea

More Details

Aug29
(thu)
2024

Liver Metastasis

Role of MRI imaging in liver metastasis treated with locoregional therapies
Role of CT and MRI in managing liver metastases from pancreatic cancer

Role of MRI imaging in liver metastasis treated with locoregional therapies

Role of MRI imaging in liver metastasis treated with locoregional therapies

Dr. Nutcha Pinjaroen
Radiology Department, Faculty of Medicine Chulalongkorn University,
Bangkok, Thailand

Role of CT and MRI in managing liver metastases from pancreatic cancer

Role of CT and MRI in managing liver metastases from pancreatic cancer

Dr. Atsushi Oba
Department of Hepatobiliary Pancreatic Surgery,
Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

More Details